0

Hypertension Collection
 101-120 of 674 Articles
Articles |  15 July 2003
Effect of Losartan on Microalbuminuria in Normotensive Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial
Adrienne A.M. Zandbergen, MD; Marinus G.A. Baggen, MD, PhD; Steven W.J. Lamberts, MD, PhD; et al.
Ann Intern Med. 2003;139(2):90-96. doi:10.7326/0003-4819-139-2-200307150-00008
Articles |  1 April 2003
Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy
Tomas Berl, MD; Lawrence G. Hunsicker, MD; Julia B. Lewis, MD; et al.
Ann Intern Med. 2003;138(7):542-549. doi:10.7326/0003-4819-138-7-200304010-00010
Articles |  3 September 2002
Relationship of Antihypertensive Treatment Regimens and Change in Blood Pressure to Risk for Heart Failure in Hypertensive Patients Randomly Assigned to Doxazosin or Chlorthalidone: Further Analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial
Barry R. Davis, MD, PhD; Jeffrey A. Cutler, MD; Curt D. Furberg, MD, PhD; et al.
Ann Intern Med. 2002;137(5_Part_1):313-320. doi:10.7326/0003-4819-137-5_Part_1-200209030-00006
Articles |  2 July 2002
Reporting the Recruitment Process in Clinical Trials: Who Are These Patients and How Did They Get There?
Cary P. Gross, MD; Raburn Mallory, MD; Asefeh Heiat, MD; et al.
Ann Intern Med. 2002;137(1):10-16. doi:10.7326/0003-4819-137-1-200207020-00007
Articles |  18 June 2002
The Ankle Brachial Index Is Associated with Leg Function and Physical Activity: The Walking and Leg Circulation Study
Mary McGrae McDermott, MD; Philip Greenland, MD; Kiang Liu, PhD; et al.
Ann Intern Med. 2002;136(12):873-883. doi:10.7326/0003-4819-136-12-200206180-00008
Academia and the Profession |  4 June 2002
The Placebo Effect in Alternative Medicine: Can the Performance of a Healing Ritual Have Clinical Significance?
Ted J. Kaptchuk, OMD
Ann Intern Med. 2002;136(11):817-825. doi:10.7326/0003-4819-136-11-200206040-00011
Therapeutics |  May/Jun 2002
Losartan was renoprotective in diabetic nephropathy independent of its effect on blood pressure
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):84. doi:10.7326/ACPJC-2002-136-3-084
Therapeutics |  May/Jun 2002
Irbesartan reduced progression of nephropathy caused by type 2 diabetes independent of the effect on blood pressure
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):83. doi:10.7326/ACPJC-2002-136-3-083
Therapeutics |  May/Jun 2002
Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):82. doi:10.7326/ACPJC-2002-136-3-082
Articles |  2 April 2002
Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials
Seamus P. Whelton; Ashley Chin, MPH, MA; Xue Xin, MD, MS; et al.
Ann Intern Med. 2002;136(7):493-503. doi:10.7326/0003-4819-136-7-200204020-00006
Articles |  19 March 2002
J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data
Florent Boutitie, MSc; François Gueyffier, MD; Stuart Pocock, PhD; et al.
Ann Intern Med. 2002;136(6):438-448. doi:10.7326/0003-4819-136-6-200203190-00007
Editorials |  18 December 2001
Sound Clinical Advice for Hypertensive Patients
Cynthia Mulrow, MD, MSc
Ann Intern Med. 2001;135(12):1084-1086. doi:10.7326/0003-4819-135-12-200112180-00013
Ideas and Opinions |  18 December 2001
Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Guidelines Based on Current Evidence
Norman M. Kaplan, MD
Ann Intern Med. 2001;135(12):1079-1083. doi:10.7326/0003-4819-135-12-200112180-00012
Ideas and Opinions |  18 December 2001
Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension
Curt D. Furberg, MD, PhD; Bruce M. Psaty, MD, PhD; Marco Pahor, MD; et al.
Ann Intern Med. 2001;135(12):1074-1078. doi:10.7326/0003-4819-135-12-200112180-00011
Articles |  18 December 2001
Effects of Diet and Sodium Intake on Blood Pressure: Subgroup Analysis of the DASH-Sodium Trial
William M. Vollmer, PhD; Frank M. Sacks, MD; Jamy Ard, MD; et al.
Ann Intern Med. 2001;135(12):1019-1028. doi:10.7326/0003-4819-135-12-200112180-00005
Ideas and Opinions |  6 November 2001
Clinical Inertia
Lawrence S. Phillips, MD; William T. Branch, MD; Curtiss B. Cook, MD; et al.
Ann Intern Med. 2001;135(9):825-834. doi:10.7326/0003-4819-135-9-200111060-00012
Quality Indicators for Assessing Care of Vulnerable Elders |  16 October 2001
Quality Indicators for Appropriate Medication Use in Vulnerable Elders
Eric L. Knight, MD, MPH; Jerry Avorn, MD
Ann Intern Med. 2001;135(8_Part_2):703-710. doi:10.7326/0003-4819-135-8_Part_2-200110161-00009
Quality Indicators for Assessing Care of Vulnerable Elders |  16 October 2001 FREE
ACOVE Quality Indicators
Ann Intern Med. 2001;135(8_Part_2):653-667. doi:10.7326/0003-4819-135-8_Part_2-200110161-00004
Articles |  18 September 2001
Diagnostic Tests for Renal Artery Stenosis in Patients Suspected of Having Renovascular Hypertension: A Meta-Analysis
G. Boudewijn C. Vasbinder, MD; Patricia J. Nelemans, MD, PhD; Alfons G.H. Kessels, MD, MSc; et al.
Ann Intern Med. 2001;135(6):401-411. doi:10.7326/0003-4819-135-6-200109180-00009
Academia and the Profession |  4 September 2001
Perceptions about Complementary Therapies Relative to Conventional Therapies among Adults Who Use Both: Results from a National Survey
David M. Eisenberg, MD; Ronald C. Kessler, PhD; Maria I. Van Rompay, BA; et al.
Ann Intern Med. 2001;135(5):344-351. doi:10.7326/0003-4819-135-5-200109040-00011
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)